Akums Drugs and Pharmaceuticals Ltd (AKUMS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 461.60
% Change: -1.23% (Prev Close: 467.35)

Volume: 1,77,107
% Change: -32.72% (Prev Volume: 2,63,254)

Delivery: 1,21,750
Delivery % : 68.74
% Change: -23.64% (Prev Delivery: 1,59,445)

Turnover: 821 Lacs
% Change: -32.67% (Prev Turnover: 1,220)

πŸ’Ή EOD Valuation

P/E Ratio: 21.27
P/B Ratio: 2.38
Market Cap: 7266 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: AKUMS
Market Cap: 7150 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 949.00
52 Week Low: 405.00

All-Time High: 1175.90 Rs.
All-Time Low: 405.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-5.63% | -15.97% | -5.87% | -47.15% | 0.00%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 75.26%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 4.24%

Change (3Y | 1Y): 0.00% | -1.53%

DII Holding

DII Holding: 8.85%

Change (3Y | 1Y): 0.00% | 1.46%

Public Holding: 8.92%

🏦 Financial Strength

Debt to Equity: 0.03
Debt: 88.22 Rs. Cr.

Book Value: 193.59 Rs.
Current Ratio: 2.55
Interest Coverage: 8.53
Free Cash Flow: 201.44 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: -2.47%

Sales Growth Qtr (YOY | QoQ):
0.48% | -2.99%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.27% | 3.90% | -2.47%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 30.05%

Profit Growth Qtr (YOY | QoQ):
5.50% | -56.76%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
48.93% | 49.26% | 30.05%

EPS Rs.

EPS (TTM): 21.70 Rs.

EPS Qtr (Last Year | Latest):
4.08 Rs. | 4.03 Rs.

EPS Annual (Last Annual | Annual March):
-0.28 Rs. | 21.49 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-42.93% | 37.55%

Net Profit Rs. Cr.

Net Profit (TTM): 347.27 Rs. Cr.

Net Profit (Annual - March): 343.78 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
61.21| 149.61 | 64.69

EBITDA Rs. Cr.

EBITDA (Quarter): 155.71 Rs. Cr.
EBITDA (Previous Yr Ql): 134.56 Rs. Cr.

EBITDA (Annual - March): 512.89 Rs. Cr.
EBITDA (Previous Annual): 157.18 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
20.55% | 112.21%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 11.29%

OPM Qtr (Previous | Current):
8.90% | 12.60%

OPM Annual (5 Yrs | Last Yr | March):
5.62% | 2.95% | 11.28%

Return on Equity %

ROE: 17.19%

ROE (5 Yrs | 3 Yrs | Last Yr):
6.53% | 13.14% | -2.90%

Return on Capital Employed %

ROCE: 16.20%

ROCE (5 Yrs | 3 Yrs | Last Yr):
8.96% | 13.66% | 2.40%

Return on Assets %

ROA (TTM): 8.64%

ROA (5 Yrs | 3 Yrs | Last Yr):
1.84% | 4.10% | -0.47%

PEG Ratio: 0.44
Dividend Yield: 0.00%

PE 3 Yrs: 46.82
PE 5 Yrs: 46.82

Dividend Yield: 0.00%

πŸ‘₯ Company

Akums Drugs and Pharmaceuticals Ltd

AKUMS

Promoter Holding: %